Industry News
ResMed lifts September quarter profit by 14%
ResMed (ASX:RMD) said its revenue for the September quarter increased 5%, despite what CEO Mick Farrell called a "tough competitive product cycle". [ + ]
Celebrating 20 years of medical research policy advocacy
The Association of Australian Medical Research Institutes celebrates its 20th birthday this week. [ + ]
Biotron posts early data from HIV/HCV trial
During a phase II trial, Biotron's (ASX:BIT) BIT225 has shown promise at enhancing antiviral activity in hard-to-treat HCV Genotype 3 patients undergoing the IFN/RVB treatment regimen. [ + ]
FDA clears first drug from UWA spinout iCeutica
iCeutica has won FDA approval for Zorvolex, the first drug developed using a technology platform conceived at the University of Western Australia. [ + ]
Disturbing infection trends
Annual survey shows rates of chlamydia, gonorrhoea and syphilis infection are on the increase. [ + ]
Genomic research is the name of the game
Computer scientists at McGill University have developed an online puzzle game, called Phylo, which also contributes to genetic research. The game has been played by 300,000 people over the past three years - now, its creators are making the players available to scientists around the globe. [ + ]
Vacuum technology to help refine the kilogram
Patrick Abbott, of the US National Institute of Standards and Technology (NIST), is conducting research into redefining the kilogram - the only unit of mass in the International System of Units (SI) which still relies on a physical object for its definition. [ + ]
Mesoblast forms three-way cancer R&D tie-up
Mesoblast (ASX:MSB), Ziopharm Oncology and Intrexon have teamed up to develop a new class of cell-based cancer treatments, with an initial focus on lung cancer. [ + ]
NHMRC 2013 grants announced
The outcomes of the NHMRC 2013 grant round have been announced. [ + ]
Allied Healthcare closes $10.4m rights offer
Allied Healthcare (ASX:AHZ) has raised $10.4m in a rights issue to help fund commercialisation efforts for its CardioCel heart patch. [ + ]
Australian Export Council conducts in-depth survey on exports
To better understand the export behaviour of Australian companies and help shape Australia's future trade agenda, the Australian Export Council is conducting Australia's International Business Survey. [ + ]
Imugene steps in to buy Biolife Science
Imugene (ASX:IMU) has agreed to buy Biolife Science, the cancer immunotherapy company that called off a backdoor ASX listing and capital raising earlier this year. [ + ]
Immuron granted US Travelan patent
Immuron (ASX:IMC) has secured a US patent covering products developed with its colostrum platform technology, as it progresses with talks to bring Travelan to the US. [ + ]
Last chance to register for the biotech industry event of the year: AusBiotech 2013
Brisbane will welcome more than 1000 of the brightest brains in biotechnology and innovation next week for the official launch of the AusBiotech 2013 national conference; a premier event on the Australian and Asia-Pacific calendar. [ + ]
Melbourne hosts biotech investment conference
Life sciences investment event AusBiotech Invest Conference will take place from 28-29 October at the Melbourne Convention and Exhibition Centre. [ + ]
